Clinical Trial Update: Reduced Exposure Study in Smokers Using THS 2.2 With 5 Days in a Confinement Setting. [NA]

View source ↗

Summary

A completed reduced exposure study in smokers using THS 2.2 in confinement

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking

Drugs mentioned

• THS 2.2 (tobacco heated product variant)

Snippet

Sponsor: Philip Morris Products S.A. | Conditions: Smoking | NA | Status: COMPLETED | Results posted: 2016-10-13